Representative before the EPO

Employment test 51 - 200 employees
Company dna kilburn and strode llp
operating since 1906
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 10 EP applications James Michael Snaith has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 11, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP16762448

AZA-PYRIDONE COMPOUNDS AND USES THEREOF

IPC classification:
A61P 31/16, A61K 31/5025, C07D 471/04, C07D 487/04
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16765869

COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS

IPC classification:
A61K 36/82, A61K 31/353
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16728995

PROCESS FOR THE PREPARATION OF 2,4- OR 2,5-PYRIDINEDICARBOXYLIC ACID AND COPOLYMERS DERIVED THEREFROM

IPC classification:
C08L 67/02, C08G 63/685, C08G 63/181, C12P 17/12, C12P 7/50, C12P 7/44
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16728991

PROCESSES FOR THE FORMATION OF FURANDICARBOXYLIC ACID (FDCA) VIA A MULTISTEP BIOCATALYTIC OXIDATION REACTION OF 5-HYDROXYMETHYLFURFURAL (HMF)

IPC classification:
C12P 17/04, C12P 7/62, C08G 63/02, C07K 14/435
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16753801

FUMAGILLOL SPIROCYCLIC COMPOUNDS AND FUSED BICYCLIC COMPOUNDS AND THEIR USE AS METAP2 INHIBITORS

IPC classification:
A61P 3/04, A61K 31/5377, A61K 31/496, A61K 31/438, A61K 31/407, A61K 31/397, C07D 495/10, C07D 491/107, C07D 491/048, C07D 487/10, C07D 487/04, C07D 471/10, A61K 31/403, C07D 405/14
Applicant:
Zafgen, Inc.
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16756874

FUMAGILLOL HETEROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING SAME

IPC classification:
C07D 401/14, A61P 3/10, A61K 31/4523, A61K 31/4025, A61K 31/397, C07D 405/14, C07D 405/12
Applicant:
Zafgen, Inc.
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP16837716

EXTREMELY SMALL NANOPARTICLES OF DEGRADABLE POLYMERS

IPC classification:
B82Y 40/00, B82Y 30/00, B82Y 5/00, A61K 9/51, A61K 9/14, A61K 9/00
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made
EP17179729

QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

IPC classification:
A61P 35/00, A61K 31/517, C07D 403/12
Applicant:
AstraZeneca AB
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
The application has been published
EP17208143

METHOD FOR ALKALIATING ANODES

IPC classification:
H01M 4/139, H01M 4/04, C25D 3/54, C25D 3/66
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
The application has been published
EP16858314

EXCIPIENT COMPOUNDS FOR BIOPOLYMER FORMULATIONS

IPC classification:
A61K 47/18, A61K 47/12, A61K 47/06, A61K 39/395, A61K 38/00, A61K 47/22
Agent:
James Michael Snaith, Kilburn & Strode LLP
Status:
Request for examination was made

Please Sign in to use this feature